CCM
MRNA icon

Cinctive Capital Management’s Moderna MRNA Stock Holding History

Cinctive Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,000
Closed -$705K – 609
2021
Q2 		$705K Buy
+3,000
New +$536K 0.03% 390

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cinctive Capital Management's MRNA Position: Q1 2026 in Review

Cinctive Capital Management increased its Moderna (MRNA) stake by 5.1% in Q1 2026, buying an estimated $171K and bringing the position to 76,043 shares worth $3.86M. The position accounts for 0.25% of the portfolio, ranked #137.

Cinctive Capital Management first reported a position in MRNA in Q4 2020 and has held it in 5 quarters since. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Cinctive Capital Management held 76,043 shares of Moderna worth $3.86M as of Q1 2026.
  • Cinctive Capital Management bought 3,667 Moderna shares in Q1 2026, an estimated $171K.
  • Moderna made up 0.25% of Cinctive Capital Management's portfolio in Q1 2026, its #137 holding.
  • Cinctive Capital Management first reported a position in Moderna in Q4 2020 and has held it in 5 quarters since.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.